Therapeutic possibilities in non-Hodgkin's lymphoma
Klener, P.
Vnitrni Lekarstvi 43(5): 320-325
1997
ISSN/ISBN: 0042-773X PMID: 9601857 Document Number: 481069
The author presents a review of optimal therapeutic procedures in the treatment of non-Hodgkin lymphomas (NHL) with a low and high grade malignity. He emphasizes that the prerequisite of successful treatment is detailed assessment of the type of NHL, the extent of the disease and prognostic signs. Therefore a brief account of diagnostic procedures is presented, incl.molecular biological diagnosis.
Document emailed within 1 workday
Related Documents
Klener, P. 1983: Modern treatment possibilities in non-Hodgkin's lymphoma Vnitrni Lekarstvi 29(2): 168-178Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Bellini, M.; Salvatore, G.; Di Palma, R.; Cataneo, M.; Pede, A.; De Martino, C. 2003: Gastric non-Hodgkin lymphoma: guidelines for the therapeutic approach Chirurgia Italiana 55(3): 391-397
Wörmann, B.; Unterhalt, M.; Hiddemann, W. 1993: Therapeutic strategies of mildly malignant non-Hodgkin's lymphoma Der Internist 34(2): 132-138
Fisher, R.I. 2000: Current therapeutic paradigm for the treatment of non-Hodgkin's lymphoma Seminars in Oncology 27(6 Suppl. 12): 2-8
Staak, J.O.; Dietlein, M.; Engert, A.; Weihrauch, M.R.; Schomäcker, K.; Fischer, T.; Eschner, W.; Borchmann, P.; Diehl, V.; Schicha, H.; Schnell, R. 2003: Hodgkin's lymphoma in nuclear medicine: diagnostic and therapeutic aspects Nuklearmedizin. Nuclear Medicine 42(1): 19-24
Montanari, F.; Diefenbach, C.S.M. 2015: Hodgkin lymphoma: targeting the tumor microenvironment as a therapeutic strategy Clinical Advances in Hematology and Oncology: H&o 13(8): 518-524
Hoppe, B.S.; Flampouri, S.; Lynch, J.; Slayton, W.; Zaiden, R.; Li, Z.; Mendenhall, N.P. 2012: Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy Oncology 26(5): 456-459; 462-465
Bottani, G.; Lucev, M.; Morone, C. 1984: Diagnostic and therapeutic problems of primary malignant non-Hodgkin's lymphoma of the stomach Minerva Chirurgica 39(23-24): 1671-1678
Weil, M. 1981: Therapeutic methods for meningitis in acute lymphoblastic leukemia and Hodgkin's lymphoma Nouvelle Revue Francaise d'Hematologie 23(5): 303-304
Bogusławska-Jaworska, J.; Grześkowiak-Melanowska, J.; Kaczmarek, M.; Kościelniak, E.; Legutko, L.; Sońta-Jakimczyk, D.; Sroczyńska, M.; Wojcik, Z. 1980: Preliminary therapeutic results of treatment of non-Hodgkin lymphoma in children according to the BACOP program Pediatria Polska 55(2): 207-210
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Montalban, C.; Bellas, C.; Rodriguez-Garcia, J.L.; Aguado, M.; Fernandez-Muñoz, R. 1991: Non-Hodgkin's lymphoma after prolonged remission of Hodgkin's disease in an HIV-infected patient Annals of Oncology: Official Journal of the European Society for Medical Oncology 2(8): 585-587
Rysenga, E.; Linden, M.D.; Carey, J.L.; Ross, C.W.; Schnitzer, B.; Sawdyk, M.; Maeda, K. 1995: Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease Archives of Pathology and Laboratory Medicine 119(1): 88-91
Bucerius, J.; Herkel, C.; Joe, A.Y.; Altehoefer, C.; Finke, J.; Moser, E.; Reinhardt, M.J. 2006: (18)F-FDG PET and conventional imaging for assessment of Hodgkin's disease and non Hodgkin's lymphoma. An analysis of 193 patient studies Nuklearmedizin. Nuclear medicine 45(3): 105-10; quiz N25-6
István, L.; Balázs, L.; Brittig, F.; Pócza, K.; Szentcsiki, M.; Brenner, F. 1985: Incidence of highly malignant immunoblastic non-Hodgkin lymphoma in patients with Hodgkin's disease in remission Orvosi Hetilap 126(21): 1267-1272
Gaudin, P.; Rozand, Y.; Fauconnier, J.; Phelip, X. 1995: Rheumatic manifestations at presentation of Hodgkin's disease and non-Hodgkin's malignant lymphoma. A national survey of one hundred forty-six patients Revue du Rhumatisme 62(5): 365-375
Fernández-Llamazares, J.; de la Cruz, J.; Bianchi, A.; Ribera, J.M. 1999: Primary non-Hodgkin's lymphoma of the esophagus following Hodgkin's disease Medicina Clinica 112(9): 356-357
Fedder, G.; Somers, R. 1982: Non-Hodgkin lymphoma following radio- and chemotherapy of Hodgkin's disease Nederlands Tijdschrift Voor Geneeskunde 126(38): 1730-1733
Avalos, B.R.; Klein, J.L.; Kapoor, N.; Tutschka, P.J.; Klein, J.P.; Copelan, E.A. 1993: Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu/CY Bone Marrow Transplantation 12(2): 133-138